Atlas Trials

Efficacy and Safety of Biphasic Insulin Aspart 30 for the Treatment of Type 2 Diabetes Mellitus

Clinical trial NCT01542060 · COMPLETED

Trial details

NCT number
NCT01542060
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Study type
OBSERVATIONAL
DiabetesDiabetes Mellitus, Type 2
Start date
2004-01-01
Primary completion
2004-12-01
Enrollment
298

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.